Edition:
United Kingdom

PhaseRx Inc (PZRX.OQ)

PZRX.OQ on NASDAQ Stock Exchange Capital Market

0.51USD
4:46pm GMT
Change (% chg)

$-0.03 (-5.56%)
Prev Close
$0.54
Open
$0.60
Day's High
$0.60
Day's Low
$0.51
Volume
39,040
Avg. Vol
163,651
52-wk High
$1.95
52-wk Low
$0.51

Latest Key Developments (Source: Significant Developments)

PhaseRx Receives Decision From Nasdaq Hearings Panel For Continued Listing Of Shares
12:05pm GMT 

Dec 13 (Reuters) - PhaseRx Inc ::PHASERX RECEIVES DECISION FROM THE NASDAQ HEARINGS PANEL FOR CONTINUED LISTING OF SHARES.PHASERX INC - BEEN GRANTED REQUEST FOR CONTINUED LISTING ON NASDAQ CAPITAL MARKET UNTIL JANUARY 31, 2018.  Full Article

Phaserx Commences Voluntary Chapter 11 Bankruptcy Protection Proceeding
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Phaserx Inc ::PHASERX COMMENCES VOLUNTARY CHAPTER 11 BANKRUPTCY PROTECTION PROCEEDING.PHASERX - WORKING WITH COWEN AND COMPANY TO REVIEW ALTERNATIVES.PHASERX - ALTERNATIVES MAY INCLUDE COLLABORATION WITH 1/MORE PARTIES OR LICENSING, SALE/DIVESTITURE OF SOME, OR ALL, OF CO'S PROPRIETARY TECHNOLOGIES​.  Full Article

PhaseRx reports Q3 loss per share $0.23
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - PhaseRx Inc :PhaseRx reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.23.PhaseRx Inc - ‍As of September 30, 2017, company had cash and cash equivalents of $5.3 million​.  Full Article

Phaserx gets delisting notice from NASDAQ
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Phaserx Inc ::Says receipt of delisting notice from NASDAQ informing trading in co's stock will be suspended from NASDAQ at opening of business on Nov 1​.  Full Article

Phaserx announces corporate restructuring and review of strategic alternatives
Friday, 13 Oct 2017 

Oct 13 (Reuters) - PhaseRx Inc :PhaseRx announces corporate restructuring and review of strategic alternatives.PhaseRx inc - ‍Reorganization includes a reduction in PhaseRx's workforce by 10 employees​.PhaseRx Inc - ‍Board of directors has also begun a review of strategic alternatives, including but not limited to a potential merger transaction​.PhaseRx Inc - ‍As of June 30, 2017, PhaseRx had cash and equivalents of $8.4 million and a total of 20 employees​.PhaseRx Inc - ‍ Board of directors has made a determination to delay development of its lead product candidate PRX-OTC​.  Full Article

Phaserx posts Q2 loss per share $1.84
Tuesday, 2 Aug 2016 

Phaserx Inc :Q2 loss per share $1.84.  Full Article

Arch Venture Fund VII reports 24.6 pct stake in Phaserx
Monday, 6 Jun 2016 

Phaserx Inc :Arch Venture Fund VII L.P reports 24.6 pct stake in Phaserx Inc, as of May 23, 2016 - SEC filing.  Full Article

Phaserx shares open at $5.50 in debut, above IPO price of $5
Wednesday, 18 May 2016 

: Phaserx shares open at $5.50 in debut, above the IPO price of $5 Further company coverage: [PZRX.O] ((Bengaluru Newsroom +1 646 223 8780;)).  Full Article

Phaserx priced its IPO of 3.7 mln shares of common stock at $5.00 per share
Wednesday, 18 May 2016 

Phaserx Inc : Priced its IPO of 3.7 million shares of common stock at an initial public offering price of $5.00 per share .Phaserx announces pricing of initial public offering.  Full Article

BRIEF-PhaseRx Receives Decision From Nasdaq Hearings Panel For Continued Listing Of Shares

* PHASERX RECEIVES DECISION FROM THE NASDAQ HEARINGS PANEL FOR CONTINUED LISTING OF SHARES